Arbutus Biopharma Corp CEO William Collier's 2020 pay rises 17% to $2.7M
Arbutus Biopharma Corp reports 2020 executive compensation
By ExecPay News
Published: April 8, 2021
Arbutus Biopharma Corp reported fiscal year 2020 executive compensation information on April 8, 2021.
In 2020, three executives at Arbutus Biopharma Corp received on average a compensation package of $1.7M, a 17% decrease compared to previous year.
Average pay of disclosed executives at Arbutus Biopharma Corp
William H. Collier, Chief Executive Officer, received $2.7M in total, which increased by 17% compared to 2019. 64% of Collier's compensation, or $1.8M, was in option awards. Collier also received $396K in non-equity incentive plan, $567K in salary, as well as $10K in other compensation.
Michael Sofia, Chief Scientific Officer, received a compensation package of $1.2M, which increased by 18% compared to previous year. 49% of the compensation package, or $605K, was in option awards.
Michael J. McElhaugh, Chief Business Officer, earned $1.1M in 2020.
Related executives
You may also like
Source: SEC filing on April 8, 2021.